Production (Stage)
Zai Lab Limited
ZLAB
$31.32
-$1.18-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 418.33M | 398.99M | 355.75M | 322.71M | 291.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 418.33M | 398.99M | 355.75M | 322.71M | 291.07M |
| Cost of Revenue | 292.37M | 281.26M | 294.10M | 275.45M | 270.32M |
| Gross Profit | 125.96M | 117.73M | 61.65M | 47.27M | 20.75M |
| SG&A Expenses | 292.97M | 298.74M | 298.75M | 300.08M | 288.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 686.45M | 681.11M | 693.96M | 676.64M | 668.43M |
| Operating Income | -268.12M | -282.12M | -338.21M | -353.92M | -377.36M |
| Income Before Tax | -252.07M | -257.10M | -270.85M | -298.33M | -338.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -252.07 | -257.10 | -270.85 | -298.33 | -338.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -252.07M | -257.10M | -270.85M | -298.33M | -338.95M |
| EBIT | -268.12M | -282.12M | -338.21M | -353.92M | -377.36M |
| EBITDA | -255.82M | -270.26M | -326.92M | -343.59M | -367.98M |
| EPS Basic | -24.91 | -25.92 | -27.80 | -30.69 | -35.00 |
| Normalized Basic EPS | -1.48 | -1.58 | -1.73 | -1.91 | -2.30 |
| EPS Diluted | -24.91 | -25.92 | -27.80 | -30.69 | -35.00 |
| Normalized Diluted EPS | -1.48 | -1.58 | -1.73 | -1.91 | -2.30 |
| Average Basic Shares Outstanding | 406.53M | 395.76M | 390.12M | 388.82M | 387.71M |
| Average Diluted Shares Outstanding | 40.65M | 39.58M | 39.01M | 38.88M | 38.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |